The import of penicillins or streptomycins not in dosage forms to Brazil is forecasted to gradually increase from 2024 to 2028. In 2023, the import value was below $20.715 million USD, the level projected for 2024. The annual growth rates indicate a year-on-year increase, starting from approximately 3.75% in 2025 compared to 2024, to around 3.18% in 2028 as compared to 2027. Over the forecast period, the compound annual growth rate (CAGR) is approximately 3.43%.

Future trends to watch for:

Potential impact of global pharmaceutical trade dynamics on import volumes.
Regulatory changes in Brazil that could affect importation of pharmaceutical raw materials.
Technological advancements in drug synthesis that could alter demand.
Economic policies influencing exchange rates and trade partnerships, which can affect import costs.